Matellio Received the CMMI® V2.0 Level-3 Certification

 Matellio Inc, a leading software engineering services company, announces that its software engineering development facilities have been appraised at CMMI DEV V2.0 Level-3 with Supplier Agreement Management (SAM) applicability. The appraisal at Maturity Level-3 with the SAM applicability model underlines its strong commitment to delivering high-quality solutions and IT services to its customers and vendors for a smooth digital transformation. The appraisal was conducted by QualityWaves Benchmark.

Aimed at transforming startups and enterprises with their cutting-edge technology solutions, Matellio is one of the handful of software engineering studios.

“A Level 3 certification from CMMI V2.0 will allow us as a global brand to enhance our business processes and project delivery approaches,” says Apoorv Gehlot, CEO, and Co-Founder, Matellio Inc.

“Clients across the world expect this level of appraisal from a leading software engineering studio like ours. This Level 3 certification from CMMI has proved the capabilities of Matellio to perform at that level.”

“Our team’s amazing performance and dedication were essential in our success in achieving CMMI Level 3 DEV & SAM 2.0 certification,” says Puneet Rao, COO, and Co-Founder, Matellio Inc. “At Matellio, we are committed to continuous improvement and excellent customer experience. This level of certification from CMMI acknowledged our efforts to create result-oriented solutions for our customers. We hope to continue to build on this momentum to qualify for higher levels of certifications.”

CMMI is a process and behavioural model that helps organizations improve capabilities and elevate the product, software, and service development processes. The Level 3 V2.0 certification indicates that the organization has continuously enhanced its operations and services based on a deep understanding of the business requirements and performance objectives. CMMI® DEV V2.0 is a new model that shows Matellio’s capabilities to provide clear and value-focused digital services to its clients for desired business outcomes.

About Matellio

Matellio is a software engineering studio offering digital transformation services and technology solutions to its clients worldwide. With hundreds of satisfied clients and over 300 accredited engineers, the company has delivered countless software solutions for various industry verticals. Global leaders like Clutch, App Futura, DesignRush, and Scrum Alliance have recognized their skills and expertise. Matellio is a proud partner with pioneers like Amazon Web Services, Microsoft, Arizona Technology Council, GE Digital Alliance, ServiceNow, HPE, etc.

Matellio Inc.

Piyush Singh

+1-408 560 1910

https://www.matellio.com

ContactContact

Categories

  • Software

GPHCC Received Funding from Santander Bank to Continue Its R+ Initiative Supporting the Recovery of Local Latino-Owned Businesses in Greater Philadelphia

 The Greater Philadelphia Hispanic Chamber of Commerce (GPHCC) has been awarded a $35,000 grant from Santander Bank to support GPHCC’s Small Business Development & Education Program’s Recalibrate, Retool, Restart (R+) Campaign, which provides tools and resources to Latino-owned businesses (LOBs) to successfully re-enter the economy after the pandemic. The funding will also be allocated to GPHCC’s Dine Latino, an initiative that combines the marketing and promotion of restaurants with technical assistance and micro grants to help offset the impact of the restrictions mitigating the spread of COVID-19.

“Santander Bank has been an important partner for GPHCC by supporting our programs over the years,” said Jennifer Rodriguez, President & CEO of GPHCC. “We are grateful for their support as this helps GPHCC focus on delivering actionable education and resources to our members and the Latino business community.”

Santander Bank awards the grant as it celebrates the resilient spirit of the small business community and the path forward for business owners who are ready to start something big.

“Santander Bank prioritizes equity in entrepreneurship and small business support and our collaboration with the Greater Philadelphia Hispanic Chamber of Commerce affords us the opportunity to deliver services that are needed now more than ever,” said Angela Moultrie, Region President of Pennsylvania, and Central New Jersey. “We applaud the good work the Chamber is doing to make Philadelphia a world-class destination for entrepreneurship and are excited to contribute to this important mission.”

GPHCC launched the R+ initiative in 2020 to help Latino-owned businesses recover, positioning them for the successful reintegration to the economy, in response to the disproportionate effect the pandemic restrictions had on LOBs. The R+ initiative, in partnership with Widener University Small Business Development Center, Community First Fund and Finanta, provides education and technical assistance, access to capital plus support through policy, advocacy and communications to raise awareness about the challenges of LOBs face coming out of the pandemic and to promote the stimulation of economic recovery in the Latinx community.

Follow GPHCC on Facebook, LinkedIn, and Twitter to stay tuned for updates as they are brought to their Coronavirus (COVID-19) hub on www.philahispanicchamber.org. They may also be reached at info@philahispanicchamber.org.

About GPHCC

The Greater Philadelphia Hispanic Chamber of Commerce (GPHCC) is a 501 C3 not-for-profit organization devoted to promoting the advancement and economic growth of Hispanic businesses and professionals in the Greater Philadelphia Region. For more information about the GPHCC, please visit: https://www.philahispanicchamber.org.

Greater Philadelphia Hispanic Chamber of Commerce

Maria Cristina Rios

215-360-8114

www.philahispanicchamber.org

ContactContact

Categories

  • Entrepreneurial Development

Hong Kong – DH received one report of serious adverse event relating to COVID-19 vaccination

 

The Department of Health (DH) announced that as of 4 pm today (March 13), one report was received from the Hospital Authority (HA) in the past 24 hours regarding a case admitted to the intensive care unit (ICU) with suspected serious adverse event following COVID-19 vaccination.
      
     According to the information provided by the HA, the case involved a 63-year-old man who has history of atrial fibrillation, congestive heart failure, polycythemia, and alcoholic fatty liver. He started to have generalised malaise on March 10. Today, his general condition decreased and he attended the Accident and Emergency Department of North District Hospital. He was subsequently transferred to the ICU for further treatment with provisional diagnosis of acute stroke. He is now in critical condition. According to information, he received a dose of CoronaVac COVID-19 vaccination at Yuen Wo Road Sports Centre Community Vaccination Centre in Sha Tin four days before admission (March 9) and there was no record that the man complained of feeling unwell during observation at the Vaccination Centre. 

     The DH has immediately contacted the HA upon the notification to obtain further information on the incident for conducting investigation and assessment. According to the established mechanism, the DH will provide the case to the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation for conducting causality assessment, and the assessment result will be released in a timely manner. 

     ​According to the World Health Organization, Adverse Events Following Immunisation refers to any untoward medical occurrence which follows immunisation and which does not necessarily have a causal relationship with the usage of the vaccine. As a whole population, people with acute medical conditions with various severity are admitted to the hospitals every day. With the commencement of the vaccination programme, among those patients with acute medical conditions, there will be those that have received vaccines and reports of such cases might increase with the increasing vaccination uptakes. It is important for the surveillance system in place to monitor these adverse events following COVID-19 vaccination and to conduct causality assessments based on scientific and objective approach to ensure that any untoward outcome would not go unnoticed.

     According to the information of the HA, in 2020, the provisional number of hospital admission due to myocardial infarction and acute ischemic stroke was about 7 300 cases and 10 300 cases respectively. People with chronic illness should seek medical attention if they feel unwell. They should also adhere to their treatment as prescribed by their doctors.
      
     Separately, the HA informed the DH today regarding a case announced on March 7 of a 80-year-old male, who received treatment in the ICU of the Caritas Medical Centre and subsequently transferred to the Princess Margaret Hospital for further treatment, had passed away this afternoon due to ischaemic bowel disease. In addition, a case announced on March 11 of a 67-year-old male who received treatment in the ICU of the Kwong Wah Hospital had passed away this afternoon.

 

Hong Kong – DH received a report of suspected serious adverse event following COVID-19 vaccination

 

he Department of Health (DH) announced that as of 4pm (March 9), one report on admission to the intensive care unit (ICU) was received from the Hospital Authority (HA) in the past 24 hours which was a suspected serious adverse event following COVID-19 vaccination.

     According to the information provided by the HA, the case involved a 51-year-old man who has history of diabetes, hypertension and hyperlipidaemia. He experienced shortness of breath since March 6 with cough and sputum. He attended the Accident and Emergency Department of Queen Elizabeth Hospital yesterday (March 8) for treatment. He was hospitalised with provisional diagnosis of acute myocardial infarction and was admitted to the ICU last night for further treatment. He is in critical condition. He received a dose of CoronaVac COVID-19 vaccination at Yuen Wo Road Sports Centre Community Vaccination Centre on March 3.

     The DH has immediately contacted the HA upon the notification to obtain further information on the incident for conducting investigation and assessment. The DH will provide the case to the Expert Committee on Clinical Events Assessment Following COVID-19 Immunization for conducting causality assessment, and the assessment result will be released in a timely manner.

     According to the product information of the vaccine, patients with uncontrolled severe chronic diseases should not be given the vaccine. For patients with acute diseases, acute exacerbation of chronic diseases, severe chronic diseases, atopy and fever, the vaccine should be used with caution; if necessary, delay vaccination after doctor’s evaluation, a DH spokesman urged.

     As a whole population, people with acute medical conditions with various severity are admitted to the hospitals every day. With the commencement of the vaccination programme, among those patients with acute medical conditions, there will be those that have received vaccines and reports of such cases might increase with the increasing vaccination uptakes. It is important for the surveillance system in place to monitor these adverse events following COVID-19 vaccination and to conduct causality assessments based on scientific and objective approach to ensure that any untoward outcome would not go unnoticed, the spokesman added.

     According to the mortality rates in Hong Kong, on average 10.2 persons, 8.1 persons and 1.4 persons passed away every day respectively due to ischemic heart diseases, cerebrovascular diseases and diabetes in 2019. In addition, according to the information of the HA, in 2020, the number of hospital admission due to myocardial infarction was about 7 300 cases; and the number of hospital admission due to acute ischemic stroke was about 10 300 cases. People with chronic illness should seek medical attention if they feel unwell. They should also adhere to their treatment as prescribed by their doctors. 

 

Hong Kong – DH received two reports of suspected serious adverse event following COVID-19 vaccination

 

The Department of Health (DH) announced that as of 6pm today (March 7), two reports were received from the Hospital Authority (HA) in the past 24 hours regarding cases admitted to the intensive care unit (ICU) with suspected serious adverse events following COVID-19 vaccination.

     According to the information provided by the HA, the first case involved an 80-year-old man who has history of diabetes, carotid atherosclerosis, hypertension and stroke. He suffered from chest pain on March 6 and sought treatment at Accident & Emergency Department (AED) of Caritas Medical Centre. The patient did not respond well to treatment and was transferred to the ICU for further management on the same night. The provisional diagnosis was acute coronary syndrome and he was in critical condition. According to the information, he received COVID-19 vaccination at Tin Fai Road Sports Centre Community Vaccination Centre, Yuen Long on March 1.

     Another case involved a 72-year-old woman who has history of diabetes, hyperlipidaemia, hypertension and hypothyroidism, and received COVID-19 vaccination at Tseung Kwan O Sports Centre Community Vaccination Centre on March 6. She felt malaise after vaccination and skipped two doses of regular insulin. On the morning of March 7, she was found to have decreased general condition by her family member. She was admitted to Prince of Wales Hospital and was found to have severe diabetic ketoacidosis and transferred to the ICU for further treatment.

     The DH has immediately contacted the HA upon the notifications to obtain further information on the incidents for conducting investigation and assessment. The DH will provide the cases to the Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation for conducting causality assessment as soon as possible, and the assessment result will be released in a timely manner.